Financings in Brief: Cardiometrics
This article was originally published in The Gray Sheet
Executive Summary
Cardiometrics: Manufacturer of intravascular blood flow measurement devices commences NASDAQ trading Nov. 3 following completion of its initial public offering of 2.2 mil. shares of common stock. Cardiometrics filed a registration statement for the offering at the Securities and Exchange Commission in October ("The Gray Sheet" Oct. 16, p. 6). Shares in the IPO were priced at $9, short of the $10 to $12 range projected by the firm in its registration statement. Dillon, Read & Co. and Needham & Company managed the offering...